arbiter
JournalsPricingAccount

Bad Medicine: Pharmaceutical failure and the corporate control market

Omer Unsal & Reza Houston

Review of Quantitative Finance and Accounting2026https://doi.org/10.1007/s11156-026-01497-7article
AJG 3ABDC B
Weight
0.50

What the paper says

No abstract available.

Open paper page →

Cite this paper

https://doi.org/https://doi.org/10.1007/s11156-026-01497-7

Or copy a formatted citation

@article{omer2026,
  title        = {{Bad Medicine: Pharmaceutical failure and the corporate control market}},
  author       = {Omer Unsal & Reza Houston},
  journal      = {Review of Quantitative Finance and Accounting},
  year         = {2026},
  doi          = {https://doi.org/https://doi.org/10.1007/s11156-026-01497-7},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

Bad Medicine: Pharmaceutical failure and the corporate control market

Flags are reviewed by the Arbiter methodology team within 5 business days.

Evidence weight

0.50

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.50 × 0.4 = 0.20
M · momentum0.50 × 0.15 = 0.07
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.